Naivex Dolutegravir 50mg Tablets

About Naivex Dolutegravir 50mg Tablets

Indication:

Naivex (Dolotegravir) is an FDA-approved medicine. It is used for the treatment and therapeutic approach of HIV infection. Naivex is an integrase inhibitor. By integrating blockade, HIV integrase inhibitors prevent their multiplication and can reduce the amount of HIV in the body.

Mechanism of action:

Naivex (Dolotegravir) is an HIV-1 antiviral agent. It inhibits HIV integration by binding to the active site and thus blocks the transferring step in the integration of retroviral DNA. This is an essential step in the HIV replication cycle and will result in inhibition of viral activity.

Posology and method of administration:

Take Naivex (Dolotegravir) exactly as a health care provider tells you. Naive or experienced treatment with INSTI-naive: 50 mg once a day.

Inducers:

50mg twice a day. INSTITUES experience with certain substitutions associated with INSTI resistance or clinical suspected INSTI

Resistance:

50mg twice a day. Caution: Concomitant administration of dofetilide due to increased potency of dofetilide plasma concentrations and the risk of serious and / or life-threatening events.

How to Use Naivex Dolutegravir 50mg Tablets

Always take Naivex Dolutegravir 50mg Tablets as prescribed by your physician. Swallow the tablets whole with water, ideally at the same time each day to maintain consistent blood levels. It is important not to skip doses or stop treatment without your doctor's advice, as this can affect the efficacy of your HIV management.


Storage and Handling Instructions

Store Naivex Dolutegravir Tablets in a cool, dry location, away from direct sunlight and moisture, ensuring the temperature does not exceed 30C. Always keep the tablets in their original container, securely closed, and out of reach of children. Following these guidelines preserves the medication's effectiveness.